Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48Cre/+-LSL-KrasG12D/+mice

Neoplasia (United States)

Volumn 14, Issue 12, 2012, Pages 1249-1259

  Mohammed, Altaf ^a   Janakiram, Naveena B ^a   Brewer, Misty ^a   Duff, Ashley ^a   Lightfoot, Stan ^a   Brush, Richard S ^a   Anderson, Robert E ^a   Rao, Chinthalapally V ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; ARACHIDONATE 5 LIPOXYGENASE; BETA CATENIN; CASPASE 3; CYCLIN D1; CYCLOOXYGENASE 2; FATTY ACID; K RAS PROTEIN; MESSENGER RNA; OMEGA 3 FATTY ACID; PROTEIN BCL 2; PROTEIN P21; PROTEIN P48;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOASSAY; BODY WEIGHT; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE EXPRESSION; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID DIET; MOUSE; NICK END LABELING; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84871542969     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121508     Document Type: Article

References (50)

1. American Cancer Society (2012). Cancer Facts and Figures (2012). American Cancer Society, Atlanta, GA.
2. Eckel F, Schneider G, and Schmid RM (2006). Pancreatic cancer: a review of recent advances. Expert Opin Investig Drugs 15, 1395-1410.
3. Mohammed A, Janakiram NB, Lightfoot S, Gali H, Vibhudutta A, and Rao CV (2012). Early detection and prevention of pancreatic cancer: use of genetically engineered mouse models and advanced imaging technologies. Current Med Chem 19(22), 3701-3713.
4. Ren YX, Xu GM, Li ZS, and Song YG (2004). Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. World J Gastroenterol 10, 881-884.
5. Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, Boivin GP, Furth EE, Furukawa T, Klein A, Klimstra DS, et al. (2006). Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66, 95-106.
6. Mazur PK and Siveke JT (2011). Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology. Gut 61, 1488-1500.
7. G12D/+ transgenic mouse model. Cancer Prev Res 3, 1417-1426.
8. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, et al. (2003). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450.
9. Clinton SK and Giovannucci E (1998). Diet, nutrition, and prostate cancer. Annu Rev Nutr 18, 413-440.
10. Kolonel LN (1997). Fat and cancer. The epidemiologic evidence in perspective. Adv Exp Biol Med 422, 1-19.
11. James MJ, Gibson RA, and Cleland LG (2000). Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 71, 343S-348S.
12. Rose DP and Connolly JM (2000). Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids. Nutr Cancer 37, 119-127.
13. Ge Y, Chen ZH, Kang ZB, Brown J, Laposata M, and Kang JX (2002). Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells. Anticancer Res 22, 537-543.
14. 3 from eicosapentaenoic acid in human lung cancer cells. J Lipid Res 45, 1030-1039.
15. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, and Yu MC (2003). Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese Health Study. Br J Cancer 89, 1686-1692.
16. Maillard V, Bougnoux P, Ferrari P, Jourdan ML, Pinault M, Lavillonniere F, Body G, Le Floch O, and Chajès V (2002). N-3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Int J Cancer 98, 78-83.
17. Xia S, Wang JD, and Kang JX (2005). Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes. Carcinogenesis 26, 779-784.
18. Granados S, Quiles JL, Gil A, and Ramirez-Tortosa MC (2006). Dietary lipids and cancer. Nutr Hosp 21(2), 42-54.
19. Simopoulos AP (2006). Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 60, 502-507.
20. Larsson SC, Kumlin M, Ingelman-Sundberg M, and Wolk A (2004). Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79, 935-945.
21. Smith WL (2005). Cyclooxygenases, peroxide tone and the allure of fish oil. Curr Opin Cell Biol 17, 174-182.
22. Kelavkar UP, Hutzley J, Dhir R, Kim P, Allen KG, and McHugh K (2006). Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia 8, 112-124.
23. Kobayashi N, Barnard RJ, Henning SM, Elashoff D, Reddy ST, Cohen P, Leung P, Hong-Gonzalez J, Freedland SJ, Said J, et al. (2006). Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 12, 4662-4670.
24. Swamy MV, Citineni B, Patlolla JM, Mohammed A, Zhang Y, and Rao CV (2008). Prevention and treatment of pancreatic cancer by curcumin in combination with omega-3 fatty acids. Nutr Cancer 60(1), 81-89.
25. Simopoulos AP (2000). Human requirement for N-3 polyunsaturated fatty acids. Poultry Sci 79, 961-970.
26. Heukamp I, Gregor JI, Kilian M, Kiewert C, Jacobi CA, Schimke I, Walz MK, Guski H, and Wenger FA (2006). Influence of different dietary fat intake on liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters. Pancreatology 6, 96-102.
27. G12D/+ mice. Int J Cancer 131, 1951-1962.
28. G12D/+ mice. Neoplasia 14(9), 778-787.
29. Tanito M, Brush RS, Elliott MH, Wicker LD, Henry KR, and Anderson RE (2009). High levels of retinal membrane docosahexaenoic acid increase susceptibility to stress-induced degeneration. J Lipid Res 50, 807-819.
30. Li F, Marchette LD, Brush RS, Elliott MH, Davis KR, Anderson AG, and Anderson RE (2010). High levels of retinal docosahexaenoic acid do not protect photoreceptor degeneration in VPP transgenic mice. Mol Vis 16, 1669-1679.
31. Tanito M, Brush RS, Elliott MH, Wicker LD, Henry KR, and Anderson RE (2010). Correlation between tissue docosahexaenoic acid levels and susceptibility to light-induced retinal degeneration. Adv Exp Med Biol 664, 567-573.
32. Folch J, Lees M, and Sloan-Stanley GH (1957). A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226, 497-509.
33. Li F, Marchette LD, Brush RS, Elliott MH, Le YZ, Henry KA, Anderson AG, Zhao C, Sun X, Zhang K, et al. (2009). DHA does not protect ELOVL4 transgenic mice from retinal degeneration. Mol Vis 13(15), 1185-1193.
34. Ford DA, Monda JK, Brush RS, Anderson RE, Richards MJ, and Fliesler SJ (2008). Lipidomic analysis of the retina in a rat model of Smith-Lemli-Opitz syndrome: alterations in docosahexaenoic acid content of phospholipid molecular species. J Neurochem 105(3), 1032-1047.
35. Strouch MJ, Ding Y, Salabat MR, Melstrom LG, Adrian K, Quinn C, Pelham C, Rao S, Adrian TE, Bentrem DJ, et al. (2011). A high omega-3 fatty acid diet mitigates murine pancreatic precancer development. J Surg Res 165(1), 75-81.
36. Arshad A, Al-Leswas D, Stephenson J, Metcalfe M, and Dennison A (2011). Potential applications of fish oils rich in n-3 fatty acids in the palliative treatment of advanced pancreatic cancer. Br J Nutr 106, 795-800.
37. MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, Lim YW, Traina SB, Hilton L, Garland R, et al. (2006). Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 295, 403-415.
38. Barber MD, Fearon KC, Tisdale MJ, McMillan DC, and Ross JA (2011). Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 40, 118-124.
39. Moses AW, Slater C, Preston T, Barber MD, and Fearson KC (2004). Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids. Br J Cancer 90, 996-1002.
40. Horia E and Watkins BA (2007). Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells. Carcinogenesis 28, 809-815.
41. Lu Y, Nie D, Witt WT, Chen Q, Shen M, Xie H, Lai L, Dai Y, and Zhang J (2008). Expression of the fat-1 gene diminishes prostate cancer growth in vivo through enhancing apoptosis and inhibiting GSK-3β phosphorylation. Mol Cancer Ther 7, 3203-3211.
42. Boudreau MD, Sohn KH, Rhee SH, Lee SW, Hunt JD, and Hwang DH (2001). Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: mediation through cyclooxygenase-independent pathways. Cancer Res 61, 1386-1391.
43. Rose DP and Connolly JM (1999). Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 83, 217-244.
44. O'Connor T, Roebuck B, Peterson F, Lokesh B, Kinsella JE, and Campbell TC (1989). Effect of dietary omega-3 and omega-6 fatty acids on development of azaserineinduced preneoplastic lesions in rat pancreas. J Natl Cancer Inst 81, 858-863.
45. Park KS, Lim JW, and Kim H (2009). Inhibitory mechanism of omega-3 fatty acids in pancreatic inflammation and apoptosis. Ann N Y Acad Sci 1171, 421-427.
46. Ebbesson SO, Risica PM, Ebbesson LO, Kennish JM, and Tejero ME (2005). Omega-3 fatty acids improve glucose tolerance and components of the metabolic syndrome in Alaskan Eskimos: the Alaska Siberia project. Int J Circumpolar Health 64, 396-408.
47. Browning LM, Krebs JD, Moore CS, Mishra GD, O'Connell MA, and Jebb SA (2007). The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9, 70-80.
48. Barber M and Fearon K (2001). Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia. Lipids 36, 347-351.
49. Janakiram NB and Rao CV (2009). Role of lipoxins and resolvins as antiinflammatory and proresolving mediators in colon cancer. Cur Mol Med 9(5), 565-579.
50. Lim K, Han C, Dai Y, Shen M, and Wu T (2009). Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking β-catenin and COX-2. Mol Cancer Ther 8(11), 3046-3055.